KTR inaugurates Jamp Pharma Genome Valley facility

Published On 2022-04-07 04:30 GMT   |   Update On 2022-04-07 04:30 GMT
Advertisement

New Delhi: Hyderabad continues to consolidate its leadership position in life sciences and Genome Valley continues to be the most preferred investment destination for companies globally, said Telangana Industries and Information Technology Minister K.T. Rama Rao.

The minister on Tuesday inaugurated the facility of Jamp Pharmaceuticals Pvt. Ltd in Genome Valley here. This is the company's first facility outside Canada, and is designed to cater solid oral dosage form, powders, topicals, nasal delivery and liquid oral pharmaceutical products for regulated markets.

Advertisement

The facility is being established with the total investment of Rs 250 crore and total employment of around 200 people.

The minister said that he is happy to know that the leadership of Jamp Pharma systematically evaluated various locations in India and around the world and found Genome Valley to be the most attractive location for establishing their operations outside Canada.

Read also: Union Health Minister says Govt doesn't control essential medicines price

"This is indeed a testament to the overall ecosystem for life sciences in Telangana and also the pro-business policies of the Telangana government," said KTR, as the minister is popularly known.

Jamp Pharma SVP Sukhad Juneja, Principal Secretary, Industries, Jayesh Ranjan, Telangana State Industrial Infrastructure Corporation (TSIIC) VC & MD Narsimha Reddy, and Director, Life Sciences Shathi Nagappan were present.

Read also: Dr Reddys unveils Methylprednisolone Sodium Succinate for Injection in US

Tags:    
Article Source : IANS

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News